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developed for quantifying CMV DNA in immunocompromised
patients
Results: The detection limit of TaqMan polymerase chain
reaction assay for CMV-DNA was 10 genome per reaction and
the linear measure interval was 1 to 107 copies per reac-
tion (r2 = 0.999). The reproducibility of the TaqMan assay
was initially evaluated by interassay (between-runs) and
intraassay (within-run). The interassay and intraassay coefﬁ-
cients of variation were 9.79% and 10.85%, respectively. The
speciﬁcity of the assay was determined among herpesviridae
subfamily. No positive signals were detected. Initial appli-
cation of the quantitative real-time PCR to serum of infant
indicated the effective of assay for CMV quantitation with
100% sensitivity (n = 5).
Conclusion: In-house TaqMan assays may potentially serve
as a useful tool for rapid quantiﬁcation of CMV infections in
immunocompromised patients.
doi:10.1016/j.ijid.2008.05.1323
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Isolation of inﬂuenza A virus by tissue culture is the
traditional gold standard for laboratory detection and is
important for tracking antigenic changes of the virus. How-
ever, viral isolation is not useful for rapid clinical diagnosis
of infection and is not practical for large-scale epidemi-
ological studies. The application of molecular diagnostics
overcomes these limitations and increases the detection
rate of inﬂuenza virus by 3 - 60%. Although optimal param-
eters for specimen storage to support subsequent virus
isolation have been determined, these parameters have not
been deﬁned for nucleic acid testing. In order to deﬁne these
parameters, we evaluated the ability to detect inﬂuenza
A virus by molecular assays under different storage condi-
tions, including temperature, storage medium, and time.
We analyzed samples kept in different storage temperatures
(4 ◦C, −20 ◦C, −70 ◦C), storage time (1, 7, 14 and 28 days)
and different storage medium (viral transport medium or
ethanol). These conditions were evaluated for both swabs
and extracted RNA samples. The Luminex multiplex bead-
based assay was used for molecular detection of inﬂuenza
A virus matrix gene and hemagluttinin subytping. Although
we were able to detect inﬂuenza A virus in all storage
conditions, there was a 25—42% decrease in the mean ﬂuo-
rescent intensity (MFI) signal over time for both matrix and
hemaglutinnin for swabs stored in VTM at 4 ◦C. Loss of MFI
signal by swabs stored in VTM was minized by storage at
either −20 ◦C or −70 ◦C. We did not observe a loss of MFI
signal in swabs stored in ethanol at either 4 ◦C or −20 ◦C,
although a slight decrease in MFI signal was observed in
samples stored at −70 ◦C.(This really needs to be repeated,
does not agree with other results). Results of our study
suggest that ethanol storage of specimen may provide an
optimal transport medium for samples collected at remote
sites where maintenance cold-chain requirements may be
difﬁcult. Results from other respiratory viruses will also be
presented.
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Background: this study was carried out to assess the
diagnostic and prognostic value of cytomegalovirus (CMV)
determination in whole blood (heart and intestinal recip-
ients) and in biopsy tissue samples (intestinal recipients)
from transplant patients during virological surveillance and
analyse the CMV T cell response after transplantation.
Methods: we monitored 30 heart transplant recip-
ients (HTR) comprising three R-/D+ and 34 intestinal/
multivisceral transplant (SBMTR) comprising three R-/D+ by
CMV pp65 antigenemia and Real Time PCR . Immunological
surveillance was done in 12 HTR and 9 SBMTR. T lymphocyte
suspensions obtained using a Ficoll gradient were processed
by ELISPOT, an immunoenzyme assay based on the search
for T cells with viral speciﬁc antigens of one of the pro-
tein markers of cell activation (IFN-gamma). Around 2000
blood samples and 1200 intestinal biopsy specimens were
processed for virological tests and 56 were analysed by
ELISPOT
Results: 70% (21/30) and 44% (15/34) of HTR and SBMTR
developed active CMV infection, respectively. Of the 21 HTR
infected four had a mild-moderate symptomatic infection
(leucopenia and fever). Of the 15 SBMTR infected patients
two had a severe symptomatic CMV infection (pneumonia,
enteritis and rejection) which led to the patient’s death and
three had a mild infection (fever).
Conclusion: quantitative determination of CMV in blood
and organ biopsy by molecular tests is the elective assay for
monitoring viral load, since it directly correlates with viral
replication and clinical symptoms. The preliminary outcome
of immunological monitoring shows i) a CMV T-cell immune
response in the ﬁrst month after transplantation was asso-
ciated with a reduction in mean and peak CMV viral load
and; ii) a good and early reconstitution or development of
the CMV-speciﬁc T-cell response can shorten the duration of
CMV infection and control the risk to incur repeated episodes
linked to a recurrent infection.
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